- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bioceres Crop Solutions Corp (BIOX)
Bioceres Crop Solutions Corp stock price live, this page displays NASDAQ BIOX stock exchange data. View the BIOX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bioceres Crop Solutions Corp real time stock price chart below.
What Is the Bioceres Crop Solutions Corp Stock Price Today?
The Bioceres Crop Solutions Corp stock price today is 4.65.
What Is the Stock Symbol for Bioceres Crop Solutions Corp?
The stock symbol for Bioceres Crop Solutions Corp is "BIOX."
What Stock Exchange Does Bioceres Crop Solutions Corp Trade On?
Bioceres Crop Solutions Corp is listed and trades on the NASDAQ stock exchange.
Is Bioceres Crop Solutions Corp a Good Stock to Buy?
Determining whether Bioceres Crop Solutions Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOX quote. (ISIN: KYG1117K1141)
What Is the Bioceres Crop Solutions Corp Stock Price Today?
The Bioceres Crop Solutions Corp stock price today is 4.65.
What Is the Stock Symbol for Bioceres Crop Solutions Corp?
The stock symbol for Bioceres Crop Solutions Corp is "BIOX."
What Stock Exchange Does Bioceres Crop Solutions Corp Trade On?
Bioceres Crop Solutions Corp is listed and trades on the NASDAQ stock exchange.
Is Bioceres Crop Solutions Corp a Good Stock to Buy?
Determining whether Bioceres Crop Solutions Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIOX quote. (ISIN: KYG1117K1141)
4.65
+0.12(+2.65%)
Closed·
After Hours
4.650.00(0.00%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.45
4.67
52 wk Range
3.51
11.86
BIOX Scorecard
Full Analysis
Operates with a significant debt burden
Earnings results expected tomorrow
More Info
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.454.67
52 wk Range
3.5111.86
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIOX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
7.63
Upside
+63.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Union Acquisition receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Moolec Science Announces Business Combination
- Investing.com
- Moolec Science announces major all-stock merger
- Investing.com
- Union Acquisition receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Moolec Science announces major all-stock merger
- Investing.com
Bioceres Crop Solutions Corp Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.
Bioceres Crop Solutions Corp Earnings Call Summary for Q2/2025
- Bioceres Q2 2024 EPS at $0.0095, missing $0.18 forecast; revenue at $106.7M, below $155.92M expected; stock down 4.68% after-hours
- Revenue declined 24% YoY due to Argentine market contraction; gross margin improved to 42%; adjusted EBITDA fell to $15.4M from $24M
- Company transitioning to licensing-focused seed business model; aims for stable EBITDA in Q4 2024; expanding biologicals and high-margin products
- Net debt increased to $238M with 3.3 leverage ratio; CEO acknowledges non-linear growth, emphasizes strategy refinement for predictability
- Future EPS forecasts: $0.12 for Q4 2025, $0.38 for FY 2026; analysts maintain $7-13 price targets despite current undervaluation
Last Updated: 2025-02-12, 09:44 a/m
Read Full TranscriptCompare BIOX to Peers and Sector
Metrics to compare | BIOX | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipBIOXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 194.3x | 3.1x | 1.1x | |
PEG Ratio | −2.09 | 0.02 | 0.00 | |
Price/Book | 0.9x | 1.3x | 1.6x | |
Price / LTM Sales | 0.7x | 1.8x | 1.2x | |
Upside (Analyst Target) | 61.3% | 32.1% | 27.6% | |
Fair Value Upside | Unlock | −2.0% | 3.0% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.63
(+63.98% Upside)
Earnings
Latest Release
Feb 11, 2025
EPS / Forecast
0.0095 / 0.18
Revenue / Forecast
106.70M / 155.92M
People Also Watch
FAQ
What Is the Bioceres Crop (BIOX) Stock Price Today?
The Bioceres Crop stock price today is 4.65
What Stock Exchange Does Bioceres Crop Trade On?
Bioceres Crop is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Bioceres Crop?
The stock symbol for Bioceres Crop is "BIOX."
What Is the Bioceres Crop Market Cap?
As of today, Bioceres Crop market cap is 291.61M.
What Is Bioceres Crop's Earnings Per Share (TTM)?
The Bioceres Crop EPS (TTM) is 0.02.
When Is the Next Bioceres Crop Earnings Date?
Bioceres Crop will release its next earnings report on May 20, 2025.
From a Technical Analysis Perspective, Is BIOX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.